- Filed
- May 19, 2026 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Aug 11, 2025 | 83.11M sh |
| Shares Diluted restated | Q2 2025 · Jun 29, 2025 | 81.18M sh |
| Shares Diluted | Q2 2025 · Jun 29, 2025 | 81.18M sh |
| Shares Diluted restated | Q2 2025 · Jun 29, 2025 | 80.7M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 61.11M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 54.94M sh |
| Operating Cash Flow | Q2 2025 · Jun 29, 2025 | −$7.05M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | −$7.64M |
| Long Term Debt restated | Q2 2025 · Jun 29, 2025 | $151.19M |
| Long Term Debt | Q2 2025 · Dec 29, 2024 | $147.33M |
| Short Term Debt restated | Q2 2025 · Jun 29, 2025 | $151.2M |
| Cash And Equivalents | Q2 2025 · Jun 29, 2025 | $11.13M |
| Cash And Equivalents | Q2 2025 · Dec 29, 2024 | $13.38M |
| Stockholders Equity restated | Q2 2025 · Jun 29, 2025 | −$113.69M |
| Stockholders Equity restated | Q2 2025 · Mar 30, 2025 | −$92.14M |
| Stockholders Equity | Q2 2025 · Dec 29, 2024 | −$97.54M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | −$91.97M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | −$85.08M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | −$76.81M |
| Current Liabilities restated | Q2 2025 · Jun 29, 2025 | $97.5M |
| Current Liabilities | Q2 2025 · Dec 29, 2024 | $79.44M |
| Total Liabilities restated | Q2 2025 · Jun 29, 2025 | $262.35M |
| Total Liabilities | Q2 2025 · Dec 29, 2024 | $242.01M |
| Current Assets restated | Q2 2025 · Jun 29, 2025 | $104.09M |
| Current Assets | Q2 2025 · Dec 29, 2024 | $95.6M |
| Total Assets restated | Q2 2025 · Jun 29, 2025 | $148.65M |
| Total Assets | Q2 2025 · Dec 29, 2024 | $144.47M |
| Eps Diluted | Q2 2025 · Jun 29, 2025 | −$0.34 |
| Eps Diluted restated | Q2 2025 · Jun 29, 2025 | −$0.28 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | −$0.26 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | −$0.46 |
| Eps Basic restated | Q2 2025 · Jun 29, 2025 | −$0.34 |
| Eps Basic | Q2 2025 · Jun 29, 2025 | −$0.34 |
| Eps Basic restated | Q2 2025 · Jun 29, 2025 | −$0.28 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | −$0.26 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | −$0.46 |
| Net Income restated | Q2 2025 · Jun 29, 2025 | −$27.34M |
| Net Income restated | Q2 2025 · Jun 29, 2025 | −$22.53M |
| Net Income | Q2 2025 · Jun 30, 2024 | −$15.89M |
| Net Income | Q2 2025 · Jun 30, 2024 | −$25.48M |
| Operating Income | Q2 2025 · Jun 29, 2025 | −$8.92M |
| Operating Income restated | Q2 2025 · Jun 29, 2025 | −$12.65M |
| Operating Income | Q2 2025 · Jun 30, 2024 | −$9.49M |
| Operating Income | Q2 2025 · Jun 30, 2024 | −$17.04M |
| Gross Profit | Q2 2025 · Jun 29, 2025 | $23.78M |
| Gross Profit restated | Q2 2025 · Jun 29, 2025 | $51.16M |
| Gross Profit | Q2 2025 · Jun 30, 2024 | −$892K |
| Gross Profit | Q2 2025 · Jun 30, 2024 | $1.39M |
| Cost Of Revenue | Q2 2025 · Jun 29, 2025 | $42.33M |
| Cost Of Revenue restated | Q2 2025 · Jun 29, 2025 | $93.37M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $5.38M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $13.14M |